I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Response to Abemaciclib and Immunotherapy Rechallenge with ..:
Douglas Dias e Silva
;
Guilherme Bes Borba
;
Juliana Rodrigues Beal
...
https://www.mdpi.com/1422-0067/24/4/4209. , 2023
Link:
https://doi.org/10.3390/ijms24044209
RT Journal T1
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ebed5fd688ee4b129339978569d7fda9&Exemplar=1&LAN=DE A1 Douglas Dias e Silva A1 Guilherme Bes Borba A1 Juliana Rodrigues Beal A1 Gehan Botrus A1 Akemi Osawa A1 Sérgio Eduardo Alonso Araújo A1 Fernando Moura A1 Rafael Aliosha Kaliks Guendelmann A1 Pedro Luiz Serrano Uson Junior PB MDPI AG YR 2023 K1 squamous cell lung cancer K1 lung cancer K1 nivolumab K1 ipilimumab K1 checkpoint inhibition therapy K1 abemaciclib K1 Biology (General) K1 QH301-705.5 K1 Chemistry K1 QD1-999 JF https://www.mdpi.com/1422-0067/24/4/4209 LK http://dx.doi.org/https://doi.org/10.3390/ijms24044209 DO https://doi.org/10.3390/ijms24044209 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)